Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2020-08-26 Regulatory Filings
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Publication of Shareholder Circular
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'Publication of shareholder circular in respect of authority to implement potential disposals of shares in Founded Entity.' Crucially, the text states: 'The circular setting out full details of the resolution approved by shareholders and the potential disposals is expected to be published on the Company's website today and posted to shareholders... A copy of the circular has also been submitted to the Financial Conduct Authority and will be available for inspection at the National Storage Mechanism...' This structure—announcing the availability/publication of a detailed document (the circular) rather than being the circular itself—fits the definition of a Report Publication Announcement (RPA). While it is a regulatory filing (RNS), RPA is more specific for announcements about the release of other reports/documents.
2020-08-26 English
Sonde Makes Acquisition in Vocal Biomarker Space
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated August 25, 2020. It announces that PureTech Health plc is noting an acquisition made by its Founded Entity, Sonde Health, of NeuroLex Laboratories. The text is structured as a press release, detailing corporate news (an M&A event involving a subsidiary/founded entity) and concludes with standard disclaimers and contact information, noting it is provided by 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This format strongly indicates a general regulatory announcement or press release that doesn't fit a specific financial reporting category like 10-K, ER, or IR. Since it is a formal announcement distributed via the RNS system but is not a specific financial report, the most appropriate classification is the general regulatory announcement category.
2020-08-25 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (3706 characters) and its primary purpose is to announce *when* the half-yearly results will be released (August 27, 2020), rather than containing the results themselves. It explicitly states: "PureTech Health plc plans to announce its half-yearly results for the six months ended 30 June 2020 on Thursday, 27 August 2020." This fits the definition of a Report Publication Announcement (RPA), which signals the upcoming release of a report (in this case, the Interim/Half-Yearly Report, which would typically be classified as IR). Since the document is an announcement about the publication timing, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule. The presence of the RNS Number further confirms it is a regulatory announcement.
2020-08-06 English
PureTech to Present at Wedbush PacGrow Conference
Regulatory Filings Classification · 100% confidence The document starts with an 'RNS Number' and is dated '05 August 2020'. The content announces that PureTech Health will be presenting at a conference and provides a link to a webcast under the 'Reports and Presentations' tab. This is a short announcement (3959 chars) whose primary purpose is to inform investors about an upcoming event and the availability of presentation materials, rather than being the presentation itself or a comprehensive financial report. Since it is a general regulatory announcement distributed via RNS, and it is not one of the more specific categories like IP (Investor Presentation) or ER (Earnings Release), the most appropriate classification based on the provided definitions and the 'Menu vs Meal' rule (announcement of information) is Regulatory Filings (RNS), as it is a general regulatory news service release.
2020-08-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document begins with an 'RNS Number' and explicitly states it is providing information pursuant to DTR 5.6.1 (Disclosure Guidance and Transparency Rules) regarding the Total Voting Rights and Share Capital as of a specific month-end date (31 July 2020). This type of mandatory disclosure, which updates the total number of shares and voting rights, is a standard regulatory announcement. While it contains company information, its primary function is regulatory disclosure related to share structure. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific regulatory update disseminated via RNS, and it doesn't fit perfectly into the other specific categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), it falls best under the general regulatory announcement category, RNS, or potentially a Share Issue/Capital Change (SHA) if the change was the focus, but RNS is the most accurate umbrella for this type of routine disclosure. Given the structure and the RNS header, RNS (Regulatory Filings) is the most appropriate classification for this routine regulatory update on share capital.
2020-08-03 English
Vor Appoints Life Science Leader to BOD
Board/Management Information Classification · 99% confidence The document begins with 'RNS Number : 5420U' and concludes with information about RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA). The content itself is an announcement by PureTech Health plc noting that its Founded Entity, Vor Biopharma, appointed a new director. This type of corporate event announcement, especially when disseminated via the RNS system, falls under general regulatory announcements. Since the content is a specific corporate update (management change) but is presented as a standard regulatory news service release, it fits best under the general 'Regulatory Filings' category (RNS) as a catch-all for official news service dissemination, although 'MANG' (Board/Management Information) is also relevant. Given the strong presence of RNS headers and footers, RNS is the most appropriate classification for the *format* of the filing, which is a regulatory news service release.
2020-07-30 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.